Full Text View
Tabular View
No Study Results Posted
Related Studies
Evaluation of Iron Supplementation During Darbepoetin Alfa Treatment in Prophylaxis of Severe Anaemia Chemo-Induced
This study has been terminated.
Study NCT00210002   Information provided by Institut Claudius Regaud

First Received on September 12, 2005.   Last Updated on November 13, 2006   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Neoplasms
Anemia
More general conditions related to this trial
Hematologic Diseases
Interventions listed in this trial
Darbepoetin alfa (Aranesp®)
Ferric saccharose(Venofer®)
Additional drug interventions recognized in this trial
Darbepoetin alfa
More general drug interventions related to this trial
Hematinics
Hematologic Agents
Pharmacologic Actions
Therapeutic Uses
Sponsors listed in this trial
Institut Claudius Regaud


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services